基质区CD11c阳性巨噬细胞高密度与高级别浆液性卵巢癌更长总生存相关
本研究在发现队列(N=113)和验证队列(N=121)中,用免疫组化分析高级别浆液性卵巢癌不同肿瘤区域中标记物定义的巨噬细胞亚群。发现基质区CD11c高密度与发现队列(HR 0.39;95%CI 0.23-0.68;p=0.001)和验证队列(HR 0.46;95%CI 0.22-0.93;p=0.03)更长中位总生存相关。
要点
- CD163阳性细胞是所有区域中最丰富的巨噬细胞亚型。
- 基质区CD11c高密度与更长中位总生存相关,两个队列均得到验证。
- CD11c和CD163在基质和上皮区域强相关,CD80和CD163仅在上皮区域相关。
核心结论
- 研究支持HGSC中存在临床相关的、由标记物和定位定义的巨噬细胞亚群,且各亚群独立调控。
- 基质区CD11c可作为HGSC新的预后标志物。
研究设计与样本
- 发现队列(N=113)进行免疫组化分析,CD68阳性确认CD11c、CD80和CD163阳性细胞。
- 在总肿瘤和四个肿瘤区域中对亚群标记阳性细胞评分,分析共表达、与CD8+细胞关系及生存关联。
- 验证队列(N=121)用于确认发现队列的选定结果。
主要发现
- CD163阳性细胞是所有区域中最丰富的亚型。
- CD11c和CD163亚群在基质和上皮区域强相关,CD80和CD163在上皮区域相关。
- CD80和CD11c在血管周围区域相关性低。
- CD8与CD80在肿瘤上皮主导区域强相关,CD8与CD11c在基质区域强相关。
- 基质区CD11c高密度与发现队列更长中位总生存相关(HR 0.39;95%CI 0.23-0.68;p=0.001),验证队列为(HR 0.46;95%CI 0.22-0.93;p=0.03)。
临床怎么用
- 基质区CD11c密度可能作为HGSC预后评估的候选标志物。
- 巨噬细胞亚群的标记物和定位信息有助于理解肿瘤免疫微环境的临床相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Pre-clinical studies have identified marker- and tumor compartment-defined functionally distinct macrophage subsets. Our study analyzes marker-defined macrophage subsets in different tumor compartments of high-grade serous ovarian cancer (HGSC). METHODS: A discovery cohort (N = 113) was subjected to immunohistochemistry (IHC) analyses. CD68-positivity was confirmed for CD11c-, CD80- and CD163-positive cells. Subset-marker-positive cells were scored in the total tumor and in four tumor compartments. Correlation analyses investigated co-expression of subsets, relationship to CD8+ cells and survival associations. A validation cohort (N = 121) was used to confirm selected findings from the discovery cohort. RESULTS: CD163-positve cells was the most abundant subtype in all compartments. CD11c and CD163 subsets were strongly correlated with each other in stroma and epithelial areas, whereas CD80 and CD163 were correlated in epithelial areas. CD80 and CD11c in perivascular areas showed low correlations. Strong associations were detected between CD8 and CD80 in the tumor epithelium-dominated areas, and between CD8 and CD11c in stroma areas. High stromal CD11c density was associated with a longer median overall survival in the discovery cohort (HR 0.39; CI 95%, 0.23-0.68; p = 0.001) and in the validation cohort (HR 0.46; CI 95%, 0.22-0.93; p = 0.03). CONCLUSIONS: Our study supports the existence of clinically relevant marker- and localization defined macrophage subsets in HGSC, which are independently regulated. Moreover, it suggests stromal CD11c as a novel prognostic marker in HGSC.
引用
- Corvigno S, Mezheyeuski A, De La Fuente LM, et al. High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer. Gynecol Oncol. 2020. PMID: 33032823. doi:10.1016/j.ygyno.2020.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。